Thanks for that info. Judging by the classifications in your post I'm guessing the company was pressing it by not submitting this as a class three and the FDA obviously had a different notion. We'll see if they post another time line this week. Hopefully it's not back to the starting blocks, Thanks.
News 
Market Data 
Discover 
